{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:26:31Z","timestamp":1793658391491,"version":"4.5.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008091","name":"Golestan University of Medical Sciences","doi-asserted-by":"publisher","award":["115063"],"award-info":[{"award-number":["115063"]}],"id":[{"id":"10.13039\/501100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.bbr.2026.116476","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:45:53Z","timestamp":1790264753000},"page":"116476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of PPAR modulation on cognitive function and oxidative stress in experimental Alzheimer's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"517","author":[{"given":"Narges","family":"Dashti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Ashrafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giti","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moslem","family":"Solhirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Karimi-Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer's disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bbr.2026.116476_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer's disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.1997.6750","article-title":"Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease","volume":"150","author":"Marcus","year":"1998","journal-title":"Exp. Neurol."},{"issue":"5-6","key":"10.1016\/j.bbr.2026.116476_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbabio.2006.03.013","article-title":"Generation of superoxide by the mitochondrial Complex I","volume":"1757","author":"Grivennikova","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbr.2026.116476_bib5","first-page":"83","article-title":"Mitochondrial abnormalities in Alzheimer's disease","volume":"64","author":"Silva","year":"2012","journal-title":"Possib-.-. Targets Ther. Interv. Adv. Pharmacol."},{"key":"10.1016\/j.bbr.2026.116476_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102848","article-title":"Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor \u03b3-dependent mechanism in Alzheimer's disease","volume":"66","author":"He","year":"2023","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.bbr.2026.116476_bib7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2353\/ajpath.2006.051223","article-title":"Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH\/NLH X PS-1P264L\/P264L double knock-in mouse model of Alzheimer's disease","volume":"168","author":"Anantharaman","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190350","article-title":"SIRT3 activator Honokiol attenuates \u03b2-Amyloid by modulating amyloidogenic pathway","volume":"13","author":"Ramesh","year":"2018","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1749-6632.1999.tb07842.x","article-title":"Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative\/energy brain metabolism and in behavior in adult rats","volume":"893","author":"Hoyer","year":"1999","journal-title":"Ann. New. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11597760-000000000-00000","article-title":"Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer\u2019s disease","volume":"72","author":"de la Monte","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2026.116476_bib11","article-title":"The Impact of Systemic Inflammation on Alzheimer's Disease Pathology","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell. Biol."},{"issue":"45","key":"10.1016\/j.bbr.2026.116476_bib13","doi-asserted-by":"crossref","first-page":"33247","DOI":"10.1039\/D4RA06330A","article-title":"Novel PPAR-\u03b3 agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis, in silico evaluation, PPAR-\u03b3 binding assay and transactivation and expression studies","volume":"14","author":"D","year":"2024","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pbb.2012.03.028","article-title":"Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease","volume":"102","author":"Gupta","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.bbr.2026.116476_bib15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4161\/cc.28295","article-title":"Involvement of peroxisome proliferator-activated receptor \u03b2\/\u03b4 (PPAR \u03b2\/\u03b4) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE)","volume":"13","author":"Benedetti","year":"2014","journal-title":"Cell. Cycle"},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/aps.2013.11","article-title":"Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain \u03b2-amyloid through PPAR\u03b3 activation","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","article-title":"Role of Nuclear Receptor on Regulation of BDNF and Neuroinflammation in Hippocampus of \u03b2-Amyloid Animal Model of Alzheimer\u2019s Disease","volume":"25","author":"Prakash","year":"2014","journal-title":"Neurotox. Res."},{"issue":"12","key":"10.1016\/j.bbr.2026.116476_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2174\/1389557521666210304112403","article-title":"Glitazones, PPAR and Neuroprotection","volume":"21","author":"Ashwini Prem","year":"2021","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bbr.2026.116476_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2026.116476_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104814","article-title":"Minutes of PPAR-\u03b3 agonism and neuroprotection","volume":"140","author":"Prashantha Kumar","year":"2020","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.bbr.2026.116476_bib21","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4103\/1673-5374.393102","article-title":"Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128","volume":"19","author":"Bellver-Sanchis","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbr.2026.116476_bib22","article-title":"Ginsenoside Rb1 protected PC12 cells from A\u03b2(25-35)-induced cytotoxicity via PPAR\u03b3 activation and cholesterol reduction","volume":"893","author":"Changhong","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11064-025-04433-8","article-title":"Piper Kadsura Extract and its Bioactive Components Attenuates A\u03b225\u2212 35-Induced Neurotoxicity by Modulating Glycolysis and Activating the SIRT1\/PPAR\u03b3\/GLUT1 Axis","volume":"50","author":"Ye","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2026.116476_bib24","article-title":"Macelignan mitigates oxidative and inflammatory damage in hypoxic neurons through PPAR\u03b3-dependent pathways: implications for Alzheimer\u2019s disease","author":"Chu","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/13872877251379420","article-title":"Synergistic neuroprotection of chitosan-cannabidiol nanoparticles in a rat model of Alzheimer's disease: Amelioration of cognitive deficits and neuroinflammation","volume":"108","author":"Naserramezani","year":"2025","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"5","key":"10.1016\/j.bbr.2026.116476_bib27","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s11064-022-03844-1","article-title":"Apelin-13 improves cognitive impairment and repairs hippocampal neuronal damage by activating PGC-1\u03b1\/PPAR\u03b3 signaling","volume":"48","author":"Chen","year":"2023","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s11064-020-03216-7","article-title":"Ex vivo investigation of Bexarotene and nicotinamide function as a Protect\u0131ve agent on rat Synaptosomes treated with A\u03b2 (1-42)","volume":"46","author":"Hacioglu","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2026.116476_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153956","article-title":"Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor \u03b3-dependent mechanism in an Alzheimer's disease model","volume":"98","author":"He","year":"2022","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.bbr.2026.116476_bib30","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s11064-022-03622-z","article-title":"Preventive Effect of Betaine Against Cognitive Impairments in Amyloid \u03b2 Peptide-Injected Mice Through Sirtuin1 in Hippocampus","volume":"47","author":"Ibi","year":"2022","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.bbr.2026.116476_bib31","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acschemneuro.1c00022","article-title":"Neuroprotective efficacy of co-encapsulated rosiglitazone and vorinostat nanoparticle on streptozotocin induced mice model of Alzheimer disease","volume":"12","author":"KC","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12974-017-0866-x","article-title":"YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by \u03b2-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2","volume":"14","author":"Li","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2026.116476_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1269952","article-title":"Aerobic exercise combined with chlorogenic acid exerts neuroprotective effects and reverses cognitive decline in Alzheimer\u2019s disease model mice (APP\/PS1) via the SIRT1\/\/PGC-1\u03b1\/PPAR\u03b3 signaling pathway","volume":"15","author":"Shi","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.bbr.2026.116476_bib34","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.bbadis.2016.05.016","article-title":"Cyanidin 3-O-\u03b2-glucopyranoside activates peroxisome proliferator-activated receptor-\u03b3 and alleviates cognitive impairment in the APP(swe)\/PS1(\u0394E9) mouse model","volume":"1862","author":"Song","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"23","key":"10.1016\/j.bbr.2026.116476_bib35","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1093\/hmg\/dds355","article-title":"Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice","volume":"21","author":"Dumont","year":"2012","journal-title":"Human. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/09731296251379601","article-title":"Sinensetin Shows Neuroprotective Effects in Aluminum Chloride-induced Alzheimer\u2019s Disease in Rats by Regulating BDNF\/PPAR-\u03b3\/p38MAPK\/NF-\u03baB Pathways","volume":"22","author":"Gong","year":"2026","journal-title":"Pharmacogn. Mag."},{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jphs.2024.12.005","article-title":"Research on the protective effect of Rhizoma of Anemarrhena asphodeloides on TMT induced AD mice model based on network pharmacology combined with in vitro and in vivo experimental validation","volume":"157","author":"Huang","year":"2025","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157341309788185523","article-title":"Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway","volume":"5","author":"D'Angelo","year":"2009","journal-title":"Curr. Nanosci."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib39","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1080\/21655979.2021.1967032","article-title":"Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment A\u03b225-35","volume":"12","author":"Ding","year":"2021","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.bbr.2026.116476_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jcp.25509","article-title":"Uric acid amplifies A\u03b2 amyloid effects involved in the cognitive dysfunction\/dementia: evidences from an experimental model in vitro","volume":"232","author":"Desideri","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bbr.2026.116476_bib41","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3233\/JAD-200686","article-title":"Mesenchymal stem cell-conditioned medium improves mitochondrial dysfunction and suppresses apoptosis in okadaic acid-treated SH-SY5Y cells by extracellular vesicle mitochondrial transfer","volume":"78","author":"Zhang","year":"2020","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.bbr.2026.116476_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173835","article-title":"Ginsenoside Rb1 protected PC12 cells from A\u03b225-35-induced cytotoxicity via PPAR\u03b3 activation and cholesterol reduction","volume":"893","author":"Ke","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2026.116476_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2016.01.132","article-title":"Rosiglitazone activation of PPAR\u03b3-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta\u2013induced mitochondrial dysfunction and oxidative stress","volume":"40","author":"Chiang","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"51","key":"10.1016\/j.bbr.2026.116476_bib44","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","article-title":"Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis","volume":"282","author":"Fuenzalida","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bbr.2026.116476_bib45","first-page":"754","article-title":"Vanadyl complexes work with cinnamaldehyde in promoting cell viability under the \u03b2amyloid burden in SHSY5Y neural cells","volume":"25","author":"Li","year":"2016","journal-title":"J. Chin. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2026.116476_bib46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11064-016-2093-8","article-title":"Epigallocatechin gallate attenuates \u03b2-amyloid generation and oxidative stress involvement of PPAR\u03b3 in N2a\/APP695 cells","volume":"42","author":"Zhang","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2026.116476_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108119","article-title":"Hederagenin ameliorates ferroptosis-induced damage by regulating PPAR\u03b1\/Nrf2\/GPX4 signaling pathway in HT22 cells: An in vitro and in silico study","volume":"155","author":"Feng","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbr.2026.116476_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111532","article-title":"Agnuside enhances neuronal survival and cognitive function by modulating PI3K\/AKT\/mTOR signaling in Aluminium Chloride induced Alzheimer's disease","author":"Gnanarajan","year":"2025","journal-title":"Progress. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2026.116476_bib49","article-title":"A novel extract of Dendrobium flexicaule flower: volatile components and neuroprotective potential","author":"Lu","year":"2025","journal-title":"J. Supercrit. Fluids"},{"issue":"23","key":"10.1016\/j.bbr.2026.116476_bib50","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1093\/hmg\/dds355","article-title":"Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice","volume":"21","author":"Dumont","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"20","key":"10.1016\/j.bbr.2026.116476_bib51","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.3390\/ijms20205068","article-title":"PPAR\u03b3 and cognitive performance","volume":"20","author":"d\u2019Angelo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2026.116476_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111532","article-title":"Agnuside enhances neuronal survival and cognitive function by modulating PI3K\/AKT\/mTOR signaling in Aluminium Chloride induced Alzheimer's disease","volume":"142","author":"Gnanarajan","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib53","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157015911798376325","article-title":"Impact and therapeutic potential of PPARs in Alzheimer's disease","volume":"9","author":"T. Heneka","year":"2011","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib54","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3390\/ijms24043201","article-title":"Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: leriglitazone as a promising candidate","volume":"24","author":"Pizcueta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2026.116476_bib55","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1080\/0886022X.2022.2148539","article-title":"Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-\u03baB signaling pathway in a PPAR\u03b3-dependent manner","volume":"44","author":"Wei","year":"2022","journal-title":"Ren. Fail."},{"issue":"8","key":"10.1016\/j.bbr.2026.116476_bib56","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s11064-022-03622-z","article-title":"Preventive effect of betaine against cognitive impairments in amyloid \u03b2 peptide-injected mice through sirtuin1 in hippocampus","volume":"47","author":"Ibi","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2026.116476_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.666958","article-title":"Reassessment of pioglitazone for Alzheimer\u2019s disease","volume":"15","author":"Saunders","year":"2021","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2026.116476_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(21)00043-0","article-title":"Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Burns","year":"2021","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2026.116476_bib59","first-page":"246","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharm. J."},{"issue":"5","key":"10.1016\/j.bbr.2026.116476_bib60","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"11","key":"10.1016\/j.bbr.2026.116476_bib61","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1345\/aph.1Q238","article-title":"Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease","volume":"45","author":"Miller","year":"2011","journal-title":"Ann. Pharmacother."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826004523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826004523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:34:45Z","timestamp":1793655285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432826004523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":61,"alternative-id":["S0166432826004523"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116476","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of PPAR modulation on cognitive function and oxidative stress in experimental Alzheimer's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116476"}}